Innate Pharma IPHA
NASDAQ IPHA
$1.59 +0.05 (+3.25%)
As of: Nov 11, 2026 · 3:56 PM EST

Innate Pharma (IPHA) Change in Cash (2019)

Updated

Innate Pharma (IPHA) reported Change in Cash of -$44.59 million for the quarter ended Dec 31, 2025, compared with -$4.5 million a year earlier.

Analysis

Innate Pharma (IPHA) Change in Cash (2019) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma posted Change in Cash of -$43.28 million.

  • By year, Change in Cash came in at -$4.56 million in the year ended Dec 31, 2024, -$14.73 million in the year ended Dec 31, 2023, -$20.59 million in the year ended Dec 31, 2022 and -$37.8 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Change in Cash since the quarter ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.51 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.76 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.04 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 845.00 Mn
10 Innate Pharma 142.45 Mn -64.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -3.30 Mn
API Access

Innate Pharma Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=IPHA&period=max&api_key=YOUR_API_KEY